Clinical Study To Evaluate The Effect Of Bhavitha Shilajatu In Diabetic Peripheral Neuropathy
Phase 2
- Conditions
- Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
- Registration Number
- CTRI/2024/06/068675
- Lead Sponsor
- Dr Rakesh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Metabolically stable diabetic Subjects with symptomatic Diabetic Peripheral Neuropathy.
Subjects fulfilling the diagnostic criteria.
Subjects whose HbA1c is between 6.5 to 9%.
Subjects of all gender between the age group of 40 - 65 years
Exclusion Criteria
Subjects whose HbA1c is more than 9%.
Subjects with other metabolic and endocrinal disorders.
Subjects with other causes of Polyneuropathy.
Subjects suffering from infectious diseases and non healing ulcer/ulcers.
Subjects with cardiac aliments and Nephropathy.
Subjects with Diabetic Neuropathy in stage N3 of Dyck’s staging
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method